Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- GTLB +14.4%, CURV +3.3%, HLX +3.1% (guidance), DKS +1.5%, CIEN +1.2%, HQY +0.8% (also authorizes up to $300 mln for repurchases), .
Other news:
- AURA +12.3% (to host urologic oncology investor event)
- CLOV +11.2% (subsidiary signs agreement with The Iowa Clinic, P.C. to deploy AI tech)
- MNOV +7.3% (Announces Acceptance of Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial for Presentation at the 2024 Annual NEALS (Northeast Amyotrophic Lateral Sclerosis Consortium) Meeting)
- GO +4.9% (launches new private label program)
- CLLS +3.1% (presents pre-clinical evidence)
- MGX +2.1% (preclinincal data for Lead Hemophilia A Program)
- AMD +1.7% (former VP of AI initiatives at NVDA joining company)
- ATHM +1.5% (approves new $200 mln share repurchase program)
- RYAM +1.2% (increasing prices for Cellulose Specialties products)